Intrinsic Value of S&P & Nasdaq Contact Us

Revolution Medicines, Inc. RVMD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$124.36
-15.4%

There have been 50 recent insider transactions recorded for Revolution Medicines, Inc. (RVMD), including 7 buys and 39 sells. Total insider buying was valued at $37.72M and total insider selling at $12.93M.

Notable insiders with recent activity include Mancini Anthony, Sandler Alan B., Cislini Jeff. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — RVMD

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-25 Mancini Anthony See Remarks Informative Sell 400 $97.21 $38.88K 54,400
2026-03-20 Sandler Alan B. Chief Development Officer Unknown 11,700 $102.02 $1.19M -
2026-03-20 Mancini Anthony See Remarks Unknown 26,200 $102.02 $2.67M -
2026-03-19 Cislini Jeff General Counsel Informative Sell 1,163 $97.44 $113.32K 58,518
2026-03-17 Goldsmith Mark A See Remarks Informative Sell 12,871 $99.48 $1.28M 276,698
2026-03-17 Horn Margaret A Chief Operating Officer Informative Sell 4,583 $99.48 $455.92K 157,570
2026-03-17 Kelsey Stephen Michael See Remarks Informative Sell 4,302 $99.48 $427.96K 295,398
2026-03-17 Anders Jack Chief Financial Officer Informative Sell 2,753 $99.48 $273.87K 125,512
2026-03-17 Wang Xiaolin See Remarks Informative Sell 2,010 $99.48 $199.96K 116,063
2026-03-17 Wei Lin Chief Medical Officer Informative Sell 2,073 $99.48 $206.22K 101,366
2026-03-17 Cislini Jeff General Counsel Informative Sell 1,795 $99.48 $178.57K 59,681
2026-03-04 Anderson Elizabeth M Director Gift (Given) 15,000 - - 8,215
2026-03-02 Goldsmith Mark A See Remarks Option Exercise (Sell) 30,000 $4.09 $122.7K 47,708
2026-03-01 Goldsmith Mark A See Remarks RSU Award 128,600 $102.02 $13.12M 128,600
2026-03-01 Horn Margaret A Chief Operating Officer RSU Award 47,600 $102.02 $4.86M 47,600
2026-03-01 Kelsey Stephen Michael See Remarks RSU Award 47,600 $102.02 $4.86M 47,600
2026-03-01 Anders Jack Chief Financial Officer RSU Award 45,400 $102.02 $4.63M 45,400
2026-03-01 Wang Xiaolin See Remarks RSU Award 34,000 $102.02 $3.47M 34,000
2026-03-01 Wei Lin Chief Medical Officer RSU Award 34,000 $102.02 $3.47M 34,000
2026-03-01 Cislini Jeff General Counsel RSU Award 32,500 $102.02 $3.32M 32,500
2026-02-06 Goldsmith Mark A See Remarks Option Exercise (Sell) 24,010 $0.54 $12.97K 144,493
2026-01-21 Cislini Jeff General Counsel Informative Sell 908 $115.60 $104.96K 46,976
2026-01-07 Horn Margaret A Chief Operating Officer Option Exercise (Sell) 51,406 $42.45 $2.18M 1,094
2026-01-07 Anders Jack Chief Financial Officer Option Exercise (Sell) 10,000 $42.45 $424.5K 15,900
2025-12-16 Goldsmith Mark A See Remarks Informative Sell 15,394 $76.82 $1.18M 232,469
2025-12-16 Horn Margaret A Chief Operating Officer Informative Sell 4,847 $76.82 $372.33K 141,053
2025-12-16 Kelsey Stephen Michael See Remarks Informative Sell 5,447 $76.82 $418.42K 278,600
2025-12-16 Anders Jack Chief Financial Officer Informative Sell 3,104 $77.09 $239.29K 108,065
2025-12-16 Cislini Jeff General Counsel Informative Sell 2,688 $76.82 $206.48K 47,884
2025-11-25 Goldsmith Mark A See Remarks Informative Sell 3,000 $75.00 $225K 67,424
2025-11-25 Anders Jack Chief Financial Officer Option Exercise (Sell) 5,418 $17.00 $92.11K -
2025-11-18 Goldsmith Mark A See Remarks Option Exercise (Sell) 20,000 $4.09 $81.8K 137,708
2025-11-18 Cislini Jeff General Counsel Option Exercise (Sell) 13,388 $42.45 $568.32K -
2025-11-12 Goldsmith Mark A See Remarks Gift (Received) 50,000 - - 54,498
2025-11-12 Goldsmith Mark A See Remarks Option Exercise (Sell) 20,000 $4.09 $81.8K 157,708
2025-11-11 Anders Jack Chief Financial Officer Option Exercise (Sell) 10,000 $17.00 $170K 5,418
2025-11-07 Goldsmith Mark A See Remarks Option Exercise (Sell) 26,479 $1.12 $29.66K -
2025-10-13 Kelsey Stephen Michael See Remarks Informative Sell 25,000 $48.54 $1.21M 284,047
2025-06-20 Cislini Jeff General Counsel Informative Sell 1,912 $39.61 $75.74K 54,093
2025-06-16 Goldsmith Mark A See Remarks Informative Sell 13,496 $39.83 $537.55K 428,720
2025-06-16 Horn Margaret A Chief Operating Officer Informative Sell 3,510 $39.83 $139.8K 150,675
2025-06-16 Kelsey Stephen Michael See Remarks Informative Sell 4,289 $39.83 $170.83K 289,414
2025-06-16 Anders Jack Chief Financial Officer Informative Sell 2,170 $39.83 $86.43K 113,314
2025-06-16 Wei Lin Chief Medical Officer Informative Sell 2,173 $39.83 $86.55K 90,499
2025-06-16 Cislini Jeff General Counsel Informative Sell 1,878 $39.83 $74.8K 56,005
2025-03-20 Cislini Jeff General Counsel Informative Sell 2,041 $38.71 $79.01K 57,723
2025-03-17 Goldsmith Mark A See Remarks Informative Sell 11,738 $39.04 $458.26K 441,564
2025-03-17 Horn Margaret A Chief Operating Officer Informative Sell 3,058 $39.04 $119.39K 153,533
2025-03-17 Kelsey Stephen Michael See Remarks Informative Sell 3,294 $39.04 $128.6K 293,051
2025-03-17 Anders Jack Chief Financial Officer Informative Sell 1,864 $39.04 $72.77K 115,006
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message